Officially founded in July 2019 following its acquisition by PHC Group from Thermo Fisher Scientific, Epredia builds on the heritage of trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific. The company offers a comprehensive range of solutions that actively contribute to the evolution of the anatomical pathology diagnostics market.

Although Epredia is a new entity, its roots date back to 1937, and its history is marked by decades of commitment to innovation and precision. Each product developed is the result of the work of generations of employees driven by the same ambition: to improve patient care by providing pathologists with ever more powerful tools.

Today, Epredia is an international company specialising in precision cancer diagnostics, whose mission is to improve clinical outcomes through innovative and reliable technologies. And the adventure is just beginning.